Anthony Rothschild to Piperazines
This is a "connection" page, showing publications Anthony Rothschild has written about Piperazines.
Connection Strength
0.413
-
Rothschild AJ, Mahableshwarkar AR, Jacobsen P, Yan M, Sheehan DV. Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. Eur Neuropsychopharmacol. 2012 Dec; 22(12):858-66.
Score: 0.382
-
Rothschild AJ. The diagnosis and treatment of late-life depression. J Clin Psychiatry. 1996; 57 Suppl 5:5-11.
Score: 0.030